Zeo ScientifiX (ZEOX) Operating Leases (2020 - 2022)
Zeo ScientifiX (ZEOX) posted quarterly Operating Leases of $28588.0 for Q4 2022, down 79.64% year-over-year from $140434.0 in Q4 2021, and down 45.52% quarter-over-quarter from $52477.0 in Q3 2022.
Zeo ScientifiX (ZEOX) Operating Leases (2020 - 2022) Analysis & Trends
Zeo ScientifiX's Operating Leases history runs 3 years deep, the most recent figure standing at $28588.0 for Q4 2022.
- In Q4 2022, Operating Leases fell 79.64% year-over-year to $28588.0; the TTM figure through Oct 2022 stood at $28588.0 (down 79.64% YoY), while the FY2022 annual figure was $28588.0, down 79.64% from the prior year.
- Operating Leases for Q4 2022 stood at $28588.0, down from $52477.0 in the prior quarter.
- The five-year high for Operating Leases was $207113.0 in Q2 2021, with the low at $28588.0 in Q4 2022.
- The 3-year median for Operating Leases is $77637.0 (2022), against an average of $101939.3.
- The sharpest annual moves came in 2021 and 2022: Operating Leases surged 108.61% in 2021, then tumbled 79.64% in 2022.
- Zeo ScientifiX's Operating Leases stood at $67318.0 in 2020, then soared by 108.61% to $140434.0 in 2021, then sank by 79.64% to $28588.0 in 2022.
- Business Quant data shows ZEOX's Operating Leases at $28588.0 in Q4 2022, $52477.0 in Q3 2022, and $77637.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2022 | 28,588.00 |
| Jul 31, 2022 | 52,477.00 |
| Apr 30, 2022 | 77,637.00 |
| Oct 31, 2021 | 140,434.00 |
| Jul 31, 2021 | 168,260.00 |
| Apr 30, 2021 | 207,113.00 |
| Jan 31, 2021 | 57,968.00 |
| Oct 31, 2020 | 67,318.00 |
| Jul 31, 2020 | 117,659.00 |